The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...

Over the past decade, Eli Lilly (NYSE: LLY) has produced amazing returns, becoming the largest healthcare stock in the world ...

Pfizer (NYSE: PFE) is the name behind one of the world's top-selling products: the coronavirus vaccine. It brought in more than $37 billion at its peak in 2022 and helped the company achieve $100 ...

With its strengthening growth prospects, Teva may be the best healthcare stock to put $1,000 into right now. Here's why. Image source: Getty Images.

IQVIA Holdings Inc. (NYSE:IQV) is one of the S&P 500 stocks that Jim Cramer shared his take on. Cramer called it a “great ...

Rocket Lab’s growing defense contracts, expanding Space Systems segment, and visible backlog conversion create durable revenue growth. Read why RKLB is a Buy.

Rocket Lab Corp. RKLB extended its post-earnings slide into Monday as a major delay to its highly anticipated Neutron rocket ...

Rocket Lab's strong Q4 report wasn't enough to power gains for the stock last month.

The Neutron rocket was expected to have its debut last year. Now, it’s projected to launch at the end of 2026.

Rocket Lab RKLB shares are down on Tuesday as investors look ahead to this week’s earnings report following a volatile stretch for space-related stocks. Here’s what investors need to know. Rocket Lab ...

Brokerages including Morgan Stanley, Jefferies, Macquarie and Goldman Sachs have issued fresh views on Reliance Industries, Adani Ports, Divis Labs, Uno Minda and Dixon Technologies.

If the company can get its rocket of the future to an official launch, it stands to do very well indeed.